Journal
JAMA Network Open
Publication Date
4-1-2024
Volume
7
Issue
4
First Page
e247615
Document Type
Open Access Publication
DOI
10.1001/jamanetworkopen.2024.7615
Rights and Permissions
Balevic SJ, Benjamin DK, Powderly WG, et al. Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial. JAMA Netw Open. 2024;7(4):e247615. doi:10.1001/jamanetworkopen.2024.7615. This is an open access article distributed under the terms of the CC-BY License. © 2024 Balevic SJ et al. JAMA Network Open.
Recommended Citation
Balevic, Stephen J; Benjamin, Daniel K; Powderly, William G; Smith, P Brian; Gonzalez, Daniel; McCarthy, Matthew W; Shaw, Linda K; Lindsell, Christopher J; Bozzette, Sam; Williams, Daphne; Linas, Benjamin P; Blamoun, John; Javeri, Heta; Hornik, Christoph P; and ACTIV-1 IM Study Group, "Abatacept pharmacokinetics and exposure response in patients hospitalized with COVID-19: A secondary analysis of the ACTIV-1 IM randomized clinical trial." JAMA Network Open. 7, 4. e247615 (2024).
https://digitalcommons.wustl.edu/oa_4/3738
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
